Blog: Anapol Weiss

Anapol Weiss is a top-rated national personal injury firm with a reputation for winning big. Our trial attorneys are leaders in medical malpractice, women's health litigation, personal injury, and mass torts cases. As a female majority-owned firm with a deep bench of experienced, determined trial attorneys, we are compassionate with our clients and fierce in the courtroom.

Progesterone Contraceptive Depo-Provera Linked to Meningioma Brain Tumors

Nov 27, 2024

Emerging research highlights significant risks associated with prolonged use of certain hormonal contraceptives. Studies now reveal troubling links between progesterone-based contraceptives, such as Depo-Provera, and an increased risk of intracranial meningiomas—serious brain tumors that can cause complications, including vision loss. A recent October 2024 study from the University of Cincinnati, along with pivotal research published earlier in Cancers and The BMJ, underscores the need for greater awareness and accountability regarding long-term injectable contraceptive use. October 2024 Study:...

September Study Links Prolonged Depo-Provera Use to Increased Risk of Brain Tumors

Nov 24, 2024

In September 2024, a significant study published in the journal Cancers revealed a troubling link between the prolonged use of Depo-Provera, an injectable contraceptive containing depot medroxyprogesterone acetate (dMPA), and an increased risk of developing cerebral meningiomas. The large-scale case-control study analyzed over 117,000 meningioma cases and more than one million matched controls using data spanning 2006–2022. It found that “injection exposure” to medroxyprogesterone acetate (Depo-Provera) was associated with a 53% increase in the risk...

Depo-Provera Lawsuits: Tracy Finken Magnotta Provides Update at HarrisMartin MDL CLE Conference on December 4

Nov 22, 2024

The status of the Depo-Provera meningioma lawsuits against Pfizer will be addressed by Anapol Weiss shareholder Tracy Finken Magnotta at the HarrisMartin MDL CLE Conference on Wednesday, December 4, in New York City. Magnotta and her team at Anapol Weiss filed one of the first lawsuits against Pfizer, alleging that the company failed to warn Depo-Provera users about the increased risk of developing meningioma tumors with prolonged use of the injectable contraceptive. Anapol Weiss is...

A Guide to the History of Depo-Provera

Nov 21, 2024

Depo-Provera, a widely used injectable contraceptive, has a long and complex history of development, medical applications, and controversies. Initially hailed as a breakthrough in birth control, its use has been clouded by numerous studies and global debates about its safety. Recent developments, including a 2024 study linking long-term Depo-Provera use to an increased risk of meningiomas, have raised new questions about its safety. The Discovery of Medroxyprogesterone Acetate Depo-Provera’s active ingredient, medroxyprogesterone acetate (MPA), was first synthesized...

It’s Time for the Troubled Teen Industry to Face Reality

Nov 20, 2024

Paris Hilton's Testimony: A Catalyst for Change When most people think of Paris Hilton, they picture the glamorous socialite of The Simple Life. But Hilton’s teenage years were anything but glamorous. She has bravely come forward as a survivor of abuse in the troubled teen industry, shedding light on a dark reality that has been overlooked for far too long. Her courage is a wake-up call, demanding that we confront the systemic failures that have allowed...

Ozempic and NAOIN – The American Academy of Ophthalmology Issues Statement

Nov 17, 2024

“A new study suggests patients taking semaglutide — the active ingredient in Ozempic and Wegovy — may be at higher risk of developing an eye condition that can cause blindness.” That is the first sentence of the American Academy of Ophthalmology (AAO) news release issued in response to the Harvard study published on July 3, 2024 in JAMA Ophthalmology: The eye condition, called non-arteritic anterior ischemic optic neuropathy (“NAION”), happens “when blood flow to the optic nerve...

Litigating Prison Abuse: Addressing Assault Cases Behind Bars

Nov 12, 2024

The Reality of Prison Abuse Beyond Inmate Violence While prisons are commonly portrayed in the mainstream media and Hollywood as hotspots for inmate-on-inmate sexual and physical abuse, prison staff are also responsible for abusing inmates. A December 2022 bipartisan U.S. Senate report documented the sexual abuse of female inmates in federal prisons and the disproportionate number of sexual assaults female inmates face in comparison to their male counterparts. The report found that female inmates were abused in...

Civil Justice for Crime Victims: Holding Property Owners Accountable for Safety and Security Failures

Nov 7, 2024

By: Miriam Benton Barish and Robert G. Devine, Jr. Understanding Compensation Rights for Crime Victims on Business Premises Tragically, innocent people are injured or killed as a result of criminal conduct by others. When crime occurs because of the failure to provide adequate security by the owner or operator of a premises, the victim may be entitled to compensation. Justice for Victims of Violent Crimes on Company Property Presently, the attorneys at Anapol Weiss represent the Estate of Leslie...

Violence Against Women Act -- We Have More Work to Do

Oct 30, 2024

At Anapol Weiss, a female majority-owned firm, we are dedicated to standing up for women who have suffered violent sexual abuse, particularly within the confines of their own homes. Our commitment goes beyond mere advocacy; we seek justice, protection, and lasting change for these survivors. This year marks a significant milestone with the 30th anniversary of the Violence Against Women Act (VAWA), enacted in 1994 with bipartisan support as part of the Violent Crime Control...

Anapol Weiss Files Depo Lawsuit Against Pfizer Over Alleged Meningioma Tumors Link

Oct 28, 2024

San Francisco, CA – October 28, 2024 – The law firm of Anapol Weiss, known nationally for its leadership in mass tort litigation, today announced the filing of a personal injury lawsuit on behalf of Kathleen Fazio, a 56-year-old California woman, against pharmaceutical giant Pfizer, Inc. The lawsuit, filed in the United States District Court for the Central District of California, alleges that Fazio developed an intracranial meningioma (brain tumor) as a result of her use...